CLOROX CO /DE/
$110.17
+0.71 (+0.65%) · delayed · Nov 16, 2026
Five-year price
52w $79.12 to $128.90
- Market cap
- $13.3B
- Enterprise value
- $15.7B
- P/E
- 16.9×
- 33.2× on 3y avg EPS
- EV / EBIT
- —
- FCF yield
- 5.7%
- ROIC
- —
- Debt / equity
- 7.74
- Piotroski F
- 7/9
Value scorecard · FY2025
Does it pass the value tests?
Quality
- –ROIC > 12% (5y avg)5y avg ROIC n/a
- ●ROE > 15% (5y avg)5y avg ROE 132.3%
- –Stable operating marginsMargin volatility n/a (σ, 5y)
- ●Earnings convert to cashFCF / net income 228% (5y avg)
- ○Growing revenueRevenue CAGR 5y 1.1%
- ●Shrinking share countDiluted shares -2.7% over 5y
Value
- ○P/E below 15P/E 16.9
- –EV/EBIT below 12EV/EBIT n/a
- ○FCF yield above 6%FCF yield 5.7%
- ○Price below Graham NumberGraham Number $19.72
- ○P/B below 3P/B 41.6
Safety
- ○Debt / equity below 0.5D/E 7.74
- ●Debt payable in < 4 yrs of earningsNet debt $2.3B
- –Interest coverage > 8xCoverage n/ax
- ○Current ratio > 1.5Current ratio 0.84
- ●Piotroski F-score ≥ 6F-score 7/9
Graham Defensive
- ●Adequate size (revenue > $2B)Revenue $7.1B
- ○Strong condition (current ratio ≥ 2)Current ratio 0.84
- ●Earnings stability (no loss, 10y)10 years of data
- ●Uninterrupted dividendsDividends paid every year on record
- ○Earnings growth ≥ 33% (10y, 3y avgs)EPS growth -40%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 33.2
- ○P/E × P/B ≤ 22.5Product 1378.4
Valuation lab
What do you have to believe?
At $110.17, the market is pricing in about 6.0% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt $2.3B · 121M shares · 5y revenue CAGR 1.1%
Intrinsic value
$69.40
Price
$110.17
Premium paid
59%
What the price implies
The market is paying for 6.0% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
52% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,761 | 5,973 | 6,124 | 6,214 | 6,721 | 7,341 | 7,107 | 7,389 | 7,093 | 7,104 |
| Gross profit | 2,598 | 2,671 | 2,675 | 2,728 | 3,063 | 3,199 | 2,545 | 2,908 | 3,048 | 3,213 |
| Operating income | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| Pre-tax income | 983 | 1,033 | 1,054 | 1,024 | 1,185 | 900 | 607 | 238 | 398 | 1,078 |
| Income tax | 335 | 330 | 231 | 204 | 246 | 181 | 136 | 77 | 106 | 254 |
| Net income | 648 | 701 | 823 | 820 | 939 | 710 | 462 | 149 | 280 | 810 |
| EPS (diluted) | 4.92 | 5.33 | 6.26 | 6.32 | 7.36 | 5.58 | 3.73 | 1.20 | 2.25 | 6.52 |
| Diluted shares | 132 | 132 | 132 | 130 | 128 | 127 | 124 | 124 | 125 | 124 |
Who owns it